Posters & Publications

Kymab published a report in Nature Biotechnology in March 2014 showing the engineering of mice with the full set of human antibody genes. These mice can produce an enormous range of human antibodies, which can be developed as potent drugs to treat a variety of human diseases such as cancer, autoimmune and infectious diseases.